FDA OKs Blueprint/Roche's Gavreto As Rival To Lilly's Retevmo

US Launch For RET Drug Within A Week

 
• By Kevin Grogan
  
Cheetahs
Roche and Blueprint Pursuing Lilly • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip